Comparison of the Metabolic Profiles Associated with Protonitazene and Protonitazepyne in Two Severe Poisonings
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Nitazenes represent an emerging class of new synthetic opioids characterized by a high-potency μ-opioid receptor (MOR) agonist activity. Background: We report two 20-year-old males who presented with severe neurorespiratory depression with typical opioid syndrome, but no opioid identification based on routine blood and urine screening tests. The first patient recovered with supportive care, mechanical ventilation, and naloxone infusion, whereas the second patient developed post-anoxic cardiac arrest and died from brain death. Methods: A complementary comprehensive toxicological screening using liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS) was performed, and data were processed using a dedicated molecular network strategy to profile the metabolites. Results: Protonitazene and protonitazepyne, two nitazenes differing in their ethylamine moieties (i.e., a diethyl versus a pyrrolidine substitution, respectively), were identified. We found an extensive metabolism of protonitazene, leading to the identification of multiple phase I (resulting from hydroxylation, N-desethylation, and O-despropylation) and phase II (resulting from glucuronidation) metabolites. By contrast, protonitazepyne metabolism appeared limited, with one metabolite annotated confidently, protonitazepyne acid, which resulted from the oxidative pyrrolidine ring cleavage. Concusions: To conclude, nitazene detection is highly challenging due to its extensive structural and metabolic diversity. Our findings highlight the contribution of the untargeted LC-HRMS screening approach and suggest that diagnostic product ions can serve as robust markers for nitazene identification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Analytical features of protonitazene. (A) Extracted ion chromatogram at m/z 411.2391 corresponding to the [M + H]+ ion of protonitazene from LC-HRMS data obtained following the analysis of plasma extract. (B) Experimental isotopic pattern of protonitazene and (C) MS/MS spectra of the [M + H]+ ion of protonitazene.](https://figures.cochat.ai/paper-figures/867fe7b7fb4244fea1c6ca7dad87d9fa/comparison-of-the-metabolic-profiles-associated-with-protonitazene-and-figure-2.jpg)
![Figure 3 Analytical features of protonitazepyne. (A) Extracted ion chromatogram at m/z 409.2236 corresponding to the [M + H]+ ion of protonitazepyne from LC-HRMS data obtained following the analysis of plasma extract. (B) Experimental isotopic pattern of protonitazepyne and (C) MS/MS spectra of the [M + H]+ ion of protonitazepyne.](https://figures.cochat.ai/paper-figures/4637d5c6691447a390978073862ba156/comparison-of-the-metabolic-profiles-associated-with-protonitazene-and-figure-3.jpg)
![Figure 4 Molecular network of protonitazene metabolites. Molecular network was built using the LC-HRMS data from both plasma and urine extracts. (A) Overview of the cluster of protonitazene metabolites. MS/MS spectra of the [M + H]+ ion of (B) OH-Protonitazene, (C) N-Desethyl Protonitazene, and (D) N-Desethyl OH-Protonitazene.](https://figures.cochat.ai/paper-figures/fbce2e13efbf4118814c2c82443a5913/comparison-of-the-metabolic-profiles-associated-with-protonitazene-and-figure-4.jpg)
![Figure 5 Annotation of protonitazepyne metabolite. (A) Extracted ion chromatogram at m/z 441.2131 corresponding to the [M + H]+ ion of protonitazepyne acid from LC-HRMS data obtained following the analysis of a urine extract. (B) MS/MS spectra of the [M + H]+ ion of protonitazepyne acid. (C) Proposed fragmentation pattern of protonitazepyne.](https://figures.cochat.ai/paper-figures/408215db1cad4c279df9b9faa29ebbf7/comparison-of-the-metabolic-profiles-associated-with-protonitazene-and-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical management requires opioid reversal with naloxone which has shown to improve mental status and reverse sedation in multiple exposure cases [30, 31].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across different case reports, nitazene toxicity is characterized by apneic episodes and hypoventilation, including respiratory compromise requiring manual ventilation [29–31].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many nitazenes demonstrate MOR binding affinities comparable to, or exceeding, those of morphine and fentanyl [29,30,31,32,33].”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nitazenes act as highly potent and selective μ-opioid receptor (MOR) agonists, the primary site of action for therapeutic and adverse opioid effects.”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Reports from multiple clinical, forensic, and public health investigations have all demonstrated that severe opioid toxicity can be characterized by profound respiratory depression, which is seen in nitazene compounds.”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information
Dührkop, K., Fleischauer, M., Ludwig, M., Aksenov, A. A., Melnik, A. V., Meusel, M., Dorrestein, P. C., Rousu, J., & Böcker, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0344-8 · Cited by 2,060
Feature-based molecular networking in the GNPS analysis environment
Nothias, L.-F., Petras, D., Schmid, R., Dührkop, K., Rainer, J., Sarvepalli, A., Protsyuk, I., Ernst, M., Tsugawa, H., Fleischauer, M., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0933-6 · Cited by 1,634 · cited 1×
“The molecular network was generated using the feature-based molecular networking workflow of the Global Natural Products Social (GNPS) platform and using MetGem software [32,33].”
Integrative analysis of multimodal mass spectrometry data in MZmine 3
Schmid, R., Heuckeroth, S., Korf, A., Smirnov, A., Myers, O., Dyrlund, T. S., Bushuiev, R., Murray, K. J., Hoffmann, N., Lu, M., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01690-2 · Cited by 1,241 · cited 1×
“Data processing was performed using MZmine 4.4.3 [30,31] to generate the molecular network, as described [29].”
InfluentialMetGem Software for the Generation of Molecular Networks Based on the t-SNE Algorithm
Olivon, F., Elie, N., Grelier, G., Roussi, F., Litaudon, M., & Touboul, D. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03099 · Cited by 251 · cited 1×
“The molecular network was generated using the feature-based molecular networking workflow of the Global Natural Products Social (GNPS) platform and using MetGem software [32,33].”
Reproducible mass spectrometry data processing and compound annotation in MZmine 3
Heuckeroth, S., Damiani, T., Smirnov, A., Mokshyna, O., Brungs, C., Korf, A., Smith, J. D., Stincone, P., Dreolin, N., Nothias, L.-F., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-00996-y · Cited by 167 · cited 1×
“Data processing was performed using MZmine 4.4.3 [30,31] to generate the molecular network, as described [29].”
InfluentialVandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146 · cited 4×
“Protonitazene and protonitazepyne were found in the ng/mL range in the plasma, consistent with previous reports [3,6,16].”
InfluentialDARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141
Sauer, C., Peters, F. T., Haas, C., Meyer, M. R., Fritschi, G., & Maurer, H. H. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1571 · Cited by 95 · cited 1×
“Interestingly, the opening of the pyrrolidine ring was already reported with other recreative substances such as alpha-pyrrolidinovalerophenone ( α -PVP) [40,41].”
Walton, S. E., Krotulski, A. J., & Logan, B. K. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab117 · Cited by 92 · cited 5×
“Etonitazene, first described in 1957, is, for instance, 100–1000 times more potent than morphine [3,4].”
Influential
Cited by
Nitazenes: The Emergence of a Potent Synthetic Opioid Threat
Pereira, J. R. P., Quintas, A., & Neng, N. R. (2025) · Molecules · doi:10.3390/molecules30193890 · Cited by 21
“4 ′ -hydroxy- nitazene has been identified as a common metabolite of many nitazenes and may serve as a universal biomarker for their detection [13,21,33].”
Analytical approaches for the identification and quantitation of nitazenes: a review
Mandrioli, R., Protti, M., Lecce, R. D., & Mercolini, L. (2025) · Journal of Chromatography Open · doi:10.1016/j.jcoa.2025.100305 · Cited by 7
Zhang, M., Feng, J., Chen, H., Xiang, P., Yan, H. F., & Zhao, J. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf099 · Cited by 5
Fournié, C., Labat, L., Seigle, M. L., Mégarbane, B., Houzé, P., & Magny, R. (2025) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-025-06262-8 · Cited by 4
“These findings are consistent with previous studies demonstrating the relevance of in silico fragmentation tools such as SIRIUS for xenobiotic annotation including NPS [28, 48, 49].”
InfluentialSelf-citationN-pyrrolidino isotonitazene and its metabolites in post-mortem casework
Wood, R., & Moore, R. (2026) · Journal of Analytical Toxicology · doi:10.1093/jat/bkag027 · Cited by 2
Metadata
- Authors
- Magny, R., Schiestel, T., M’Rad, A., Lefrère, B., Raphalen, J.-H., Ledochowski, S., Labat, L., Mégarbane, B., & Houzé, P.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Necker-Enfants Malades (FR)
- Service de Réanimation Polyvalente, Médipôle Lyon-Villeurbanne, Ramsay Santé, 69100 Villeurbanne, France
- Corresponding author
- Magny, Romain
- ORCID
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2025-06-05
- Volume
- 15
- Issue
- 6
- Pages
- 371
- ISSN
- 2218-1989 (ISSN-L)
- PMC
- PMC12195359
- OpenAlex
- W4411045819
- Cited by
- 14
- References
- 41
- Citations by year
- 2026: 9 · 2025: 5
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Metabolites (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- nitazenes, synthetic opioids, opioid toxicity, drug metabolism, phase I and phase II metabolites, glucuronidation, molecular network analysis, naloxone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of the Metabolic Profiles Associated with Protonitazene and Protonitazepyne in Two Severe Poisonings. https://app.cochat.ai/papers/10.3390/metabo15060371
- The paper
- Magny, R., Schiestel, T., M’Rad, A., Lefrère, B., Raphalen, J.-H., Ledochowski, S., Labat, L., Mégarbane, B., & Houzé, P. (2025). Comparison of the Metabolic Profiles Associated with Protonitazene and Protonitazepyne in Two Severe Poisonings. Metabolites. https://doi.org/10.3390/metabo15060371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.